<html>
<head>PUBMED IDs for ACKR3</head>
<body bgcolor='#C5F0F2'><h1>ACKR3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/24497931/'>CXCR7 is highly expressed in acute lymphoblastic leukemia and potentiates CXCR4 response to CXCL12.</a> October 29  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24497926/'>Mitochondrial control region alterations and breast cancer risk: a study in South Indian population.</a> December 23  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24497922/'>Genetic diversity of the KIR/HLA system and outcome of patients with metastatic colorectal cancer treated with chemotherapy.</a> October 29  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24497917/'>Phase I clinical trial of fibronectin CH296-stimulated T cell therapy in patients with advanced cancer.</a> October 29  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26413813/'>GLI1 orchestrates CXCR4/CXCR7 signaling to enhance migration and metastasis of breast cancer cells.</a> September 17  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26660071/'>Commercially available antibodies directed against Î±-adrenergic receptor subtypes and other G protein-coupled receptors with acceptable selectivity in flow cytometry experiments.</a> October 22  2015<br></body></html>
